IPF Respiratory Symptoms Management - Current Evidence
Piotr Janowiak1, Amelia Szymanowska-Narloch1, Alicja Siemińska1
1Department of Pulmonology, Medical University of Gdańsk, Gdańsk, Poland.
Frontiers in Medicine
|August 15, 2022
Summary
Idiopathic pulmonary fibrosis (IPF) management focuses on relieving severe symptoms like dyspnea and cough. This review covers current pharmacological and non-pharmacological treatments to improve quality of life for IPF patients.
Area of Science:
- Pulmonology
- Respiratory Medicine
- Clinical Therapeutics
Background:
- Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with a poor prognosis, even with anti-fibrotic treatments.
- Patients experience significant symptom burden, particularly dyspnea and cough, impacting quality of life, especially near the end of life.
Purpose of the Study:
- To review current evidence on managing the primary symptoms of IPF: dyspnea and cough.
- To explore both pharmacological and non-pharmacological therapeutic strategies for IPF symptom control.
Main Methods:
- Systematic literature search for studies on IPF symptom management.
- Analysis of pharmacological interventions for dyspnea and cough in IPF.
- Evaluation of non-pharmacological approaches, including supportive care and rehabilitation.
Main Results:
- Pharmacological options for dyspnea and cough in IPF are limited but evolving.
- Non-pharmacological strategies, such as pulmonary rehabilitation and palliative care, play a crucial role in symptom management.
- Comprehensive management integrating medical and supportive therapies is essential for improving patient outcomes.
Conclusions:
- Effective management of dyspnea and cough is critical for improving the quality of life in IPF patients.
- A multidisciplinary approach combining pharmacological and non-pharmacological interventions is recommended for optimal IPF care.
- Further research is needed to develop more targeted and effective treatments for IPF symptoms.
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
284
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
284
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
4.2K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
4.2K
01:29Acute Respiratory Failure-V
191
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
191
01:28Pneumonia IV: Management
435
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
435
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K